ArticleERJ open research2025

Real-world improvement in ultra-low-dose thoracic computed tomography scores, systemic inflammatory markers and patient-reported outcome measures after elexacaftor/tezacaftor/ivacaftor treatment.

Hisham Ibrahim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.